Denny’s Corporation to Present at CL King’s 15th Annual Best Ideas Conference on September 14, 2017
Sep 11, 2017 12:01 pm UTC| Business
SPARTANBURG, S.C., Sept. 11, 2017 -- Denny’s Corporation (NASDAQ:DENN), franchisor and operator of one of America's largest franchised full-service restaurant chains, today announced that the Company will participate in...
Interpace Diagnostics Announces New CPT Code for Reimbursement of Molecular Thyroid Test
Sep 11, 2017 12:01 pm UTC| Business
PARSIPPANY, N.J., Sept. 11, 2017 -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically useful molecular diagnostic tests and...
TESARO Summarizes ZEJULA and TSR-042 Data Presented at the 2017 ESMO Annual Meeting
Sep 11, 2017 12:01 pm UTC| Business
MADRID, Spain, Sept. 11, 2017 -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today provided a summary of ZEJULA and TSR-042, an anti-PD-1 antibody, data presented at the 2017 European...
Atara Biotherapeutics Receives Positive Health Canada Regulatory Feedback for ATA129
Sep 11, 2017 12:01 pm UTC| Business
Health Canada New Drug Submission (NDS) planned based on Phase 1 and 2 clinical results and supported by available data from anticipated MATCH and ALLELE Phase 3 studies, which are expected to be ongoing at the time of NDS...
Sep 11, 2017 12:01 pm UTC| Business
NEWARK, Calif., Sept. 11, 2017 -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need today...
Hausfeld Announces Preliminary Approval of Five Additional Settlements in FX Litigation
Sep 11, 2017 12:01 pm UTC| Business
WASHINGTON, Sept. 11, 2017 -- Hausfeld, a global claimants’ law firm dedicated to handling complex litigation, announced today that the court in In re Foreign Exchange Benchmark Rates Antitrust Litigation, 13-cv-7789...
Sep 11, 2017 12:01 pm UTC| Business
PLYMOUTH MEETING, Pa., Sept. 11, 2017 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO), today announced that an interim data analysis showed that its INO-5150 cancer immunotherapy product generated antigen-specific CD8+...
South Africa’s plan to move away from coal: 8 steps to make it succeed
Germany lowers voting age to 16 for the European elections
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects